Company earnings

PLUR Earnings Date & History

Pluri Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.

Last updated Sep 13, 2026 at 1:27 AM ET

Pluri Inc

Biotechnology

Next earnings date
Tuesday, September 15, 2026
Reporting session
After Close
EPS estimate
$-0.67
Revenue estimate
$668,100

PLUR earnings history

Report dateQuarterEPS est.EPS actualSurpriseRevenue
Thursday, February 12, 2026Q2 2026$-0.66$-0.71-7.1%$198,000
Wednesday, November 12, 2025Q1 2026$-0.75$-0.65+13.9%$316,000
Wednesday, September 17, 2025Q4 2025$-0.74$-1.00-34.3%$398,000

What the market is watching in PLUR's next report

  • The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
  • Ticker Read combines trend, relative strength and catalysts in one research view.
  • Scanners, daily catalyst context and the members-only Weekly Watchlist are included.
Free by email

Get the week's earnings by email

One free email each week: the reports that matter, when they land, and what the market is watching.

No account required. Unsubscribe any time. Research and education only, not investment advice.

Frequently asked questions

When is the next PLUR earnings date?
Pluri Inc is scheduled to report on Tuesday, September 15, 2026 (After Close). Dates can change until the company confirms them.
Does PLUR report before or after the market?
The next report is scheduled after close.
What EPS is expected for PLUR?
Consensus EPS for the upcoming quarter is $-0.67, on revenue of $668,100.

Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.

PLUR earnings discussion

Anyone can read. Any free Hyper Stocks account can join in.

Create a free account to join the discussion. Reading is open to everyone, commenting is free, no subscription needed.

Loading discussion…

Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.